Source – avenuemail.in
TV Narendran, CEO and MD, Tata Steel today inaugurated the recently established 2 bed Bone Marrow Transplant (BMT) facility at the JGMH Block of Tata Main Hospital (TMH) in the presence of R Ravi Prasad, President Tata Workers’ Union. Chanakya Chaudhary, Vice President, Corporate Services, Tata Steel and Air Marshal (Dr) Rajan Chaudhry, AVSM, VSM (Retd.), General Manager (Medical Services) were also present on the occasion.
The BMT facility – the only one its kind in Jharkhand and one of the few in the Eastern region – is a standalone dedicated facility which would bring international level care to patients from Jharkhand and adjoining areas at reasonably affordable rates. A team led by eminent Medical Oncologist Dr (Brig) Anil Kumar Dhar, ably supported by the departments of Medical Oncology, Pathology, Critical Care and Nursing under the guidance of Dr. Rajan Chaudhry has already conducted a successful transplant for a complicated case of Lymphoma. The transplant has given new lease of life to the patient.
Narendran said, “TMH has been selflessly serving the community in and around Jamshedpur for more than a hundred years. The addition of the Bone Marrow Treatment facility is a testament to the continuous effort to bring in advanced treatment for cancer care. The new facility addresses the complete ecosystem involving the entire ecosystem involving infrastructure, medical resources and research with the objective to offer state-of-the-art treatment to patients.”
R Ravi Prasad said, “With advanced treatment such as Bone Marrow Transplant now available in Jamshedpur, patients from this region will no longer need to travel across the country for such facilities. It is indeed a matter of great satisfaction that a successful transplant has already taken place. I congratulate the entire TMH team on this momentous occasion and wish them all the best in their efforts to alleviate the pain and suffering of cancer patients.”
Bone Marrow Transplant is a therapeutic treatment modality which is a boon for patients of leukemia (blood cancer), lymphomas (malignancies of the lymph nodes) and multiple myeloma (cancer of the bone marrow itself). It is also the only curative therapy for non-malignant disorders like Thalassemia and Sickle cell anemia which are endemic in this part of the country. BMT is a procedure in which the diseased bone marrow is destroyed and replaced by healthy bone marrow or stem cells transplanted from healthy cells of the patient or a matched donor.